603 related articles for article (PubMed ID: 33941085)
1. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
[TBL] [Abstract][Full Text] [Related]
2. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
[TBL] [Abstract][Full Text] [Related]
3. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
Zeng X; Song X; Ma T; Pan X; Zhou Y; Hou Y; Zhang Z; Li K; Karypis G; Cheng F
J Proteome Res; 2020 Nov; 19(11):4624-4636. PubMed ID: 32654489
[TBL] [Abstract][Full Text] [Related]
4. Task-driven knowledge graph filtering improves prioritizing drugs for repurposing.
Ratajczak F; Joblin M; Ringsquandl M; Hildebrandt M
BMC Bioinformatics; 2022 Mar; 23(1):84. PubMed ID: 35246025
[TBL] [Abstract][Full Text] [Related]
5. Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19.
Al-Saleem J; Granet R; Ramakrishnan S; Ciancetta NA; Saveson C; Gessner C; Zhou Q
J Chem Inf Model; 2021 Aug; 61(8):4058-4067. PubMed ID: 34297570
[TBL] [Abstract][Full Text] [Related]
6. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
Glinsky GV
Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
[TBL] [Abstract][Full Text] [Related]
7. Machine learning and network medicine approaches for drug repositioning for COVID-19.
Santos SS; Torres M; Galeano D; Sánchez MDM; Cernuzzi L; Paccanaro A
Patterns (N Y); 2022 Jan; 3(1):100396. PubMed ID: 34778851
[TBL] [Abstract][Full Text] [Related]
8. Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology.
Kole A; Bag AK; Pal AJ; De D
BMC Bioinformatics; 2024 Feb; 25(1):74. PubMed ID: 38365632
[TBL] [Abstract][Full Text] [Related]
9. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
10. Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2.
Bess A; Berglind F; Mukhopadhyay S; Brylinski M; Alvin C; Fattah F; Wasan KM
Front Pharmacol; 2023; 14():1297924. PubMed ID: 38186640
[No Abstract] [Full Text] [Related]
11. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
12. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
Loganathan T; Ramachandran S; Shankaran P; Nagarajan D; Mohan S S
PeerJ; 2020; 8():e9357. PubMed ID: 32566414
[TBL] [Abstract][Full Text] [Related]
13. In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19.
Mirmohammadi S; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheykharabi M; Bazzi Z
Infect Genet Evol; 2022 Sep; 103():105318. PubMed ID: 35718334
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing for COVID-19 via knowledge graph completion.
Zhang R; Hristovski D; Schutte D; Kastrin A; Fiszman M; Kilicoglu H
J Biomed Inform; 2021 Mar; 115():103696. PubMed ID: 33571675
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
16. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
[TBL] [Abstract][Full Text] [Related]
17. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
18. Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding.
Islam MK; Amaya-Ramirez D; Maigret B; Devignes MD; Aridhi S; Smaïl-Tabbone M
Sci Rep; 2023 Mar; 13(1):3643. PubMed ID: 36871056
[TBL] [Abstract][Full Text] [Related]
19. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.
Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y
ArXiv; 2022 Feb; ():. PubMed ID: 32995367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]